![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SOX4 |
Gene summary for SOX4 |
![]() |
Gene information | Species | Human | Gene symbol | SOX4 | Gene ID | 6659 |
Gene name | SRY-box transcription factor 4 | |
Gene Alias | CSS10 | |
Cytomap | 6p22.3 | |
Gene Type | protein-coding | GO ID | GO:0000075 | UniProtAcc | Q06945 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6659 | SOX4 | GSM4909280 | Human | Breast | Precancer | 3.15e-02 | 2.05e-01 | 0.0305 |
6659 | SOX4 | GSM4909281 | Human | Breast | IDC | 1.62e-19 | 4.90e-01 | 0.21 |
6659 | SOX4 | GSM4909282 | Human | Breast | IDC | 5.35e-05 | 3.25e-01 | -0.0288 |
6659 | SOX4 | GSM4909285 | Human | Breast | IDC | 1.84e-09 | 3.15e-01 | 0.21 |
6659 | SOX4 | GSM4909286 | Human | Breast | IDC | 4.56e-33 | 5.72e-01 | 0.1081 |
6659 | SOX4 | GSM4909293 | Human | Breast | IDC | 3.76e-03 | 1.30e-01 | 0.1581 |
6659 | SOX4 | GSM4909294 | Human | Breast | IDC | 4.88e-06 | -4.46e-01 | 0.2022 |
6659 | SOX4 | GSM4909296 | Human | Breast | IDC | 8.39e-03 | 7.04e-02 | 0.1524 |
6659 | SOX4 | GSM4909297 | Human | Breast | IDC | 1.63e-10 | -4.43e-02 | 0.1517 |
6659 | SOX4 | GSM4909302 | Human | Breast | IDC | 1.25e-13 | -5.79e-01 | 0.1545 |
6659 | SOX4 | GSM4909304 | Human | Breast | IDC | 9.88e-04 | -2.44e-01 | 0.1636 |
6659 | SOX4 | GSM4909311 | Human | Breast | IDC | 3.84e-33 | -3.33e-01 | 0.1534 |
6659 | SOX4 | GSM4909313 | Human | Breast | IDC | 2.12e-05 | 2.96e-01 | 0.0391 |
6659 | SOX4 | GSM4909315 | Human | Breast | IDC | 2.72e-12 | 1.93e-01 | 0.21 |
6659 | SOX4 | GSM4909316 | Human | Breast | IDC | 5.26e-04 | -3.50e-01 | 0.21 |
6659 | SOX4 | GSM4909317 | Human | Breast | IDC | 4.98e-07 | 3.98e-01 | 0.1355 |
6659 | SOX4 | GSM4909319 | Human | Breast | IDC | 1.32e-48 | -8.41e-01 | 0.1563 |
6659 | SOX4 | GSM4909320 | Human | Breast | IDC | 3.57e-02 | 1.83e-01 | 0.1575 |
6659 | SOX4 | GSM4909321 | Human | Breast | IDC | 5.88e-05 | -4.46e-02 | 0.1559 |
6659 | SOX4 | ctrl6 | Human | Breast | Precancer | 3.33e-12 | 5.34e-01 | -0.0061 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00140092 | Skin | AK | glial cell proliferation | 13/1910 | 51/18723 | 1.45e-03 | 1.06e-02 | 13 |
GO:00455804 | Skin | AK | regulation of T cell differentiation | 27/1910 | 146/18723 | 1.64e-03 | 1.16e-02 | 27 |
GO:19019836 | Skin | AK | regulation of protein acetylation | 17/1910 | 77/18723 | 1.66e-03 | 1.18e-02 | 17 |
GO:00032815 | Skin | AK | ventricular septum development | 16/1910 | 71/18723 | 1.80e-03 | 1.24e-02 | 16 |
GO:00313651 | Skin | AK | N-terminal protein amino acid modification | 9/1910 | 30/18723 | 2.30e-03 | 1.52e-02 | 9 |
GO:19028074 | Skin | AK | negative regulation of cell cycle G1/S phase transition | 19/1910 | 93/18723 | 2.39e-03 | 1.57e-02 | 19 |
GO:00350191 | Skin | AK | somatic stem cell population maintenance | 11/1910 | 42/18723 | 2.61e-03 | 1.68e-02 | 11 |
GO:00000776 | Skin | AK | DNA damage checkpoint | 22/1910 | 115/18723 | 2.74e-03 | 1.74e-02 | 22 |
GO:00032054 | Skin | AK | cardiac chamber development | 28/1910 | 161/18723 | 3.44e-03 | 2.09e-02 | 28 |
GO:00018227 | Skin | AK | kidney development | 45/1910 | 293/18723 | 3.50e-03 | 2.12e-02 | 45 |
GO:00109485 | Skin | AK | negative regulation of cell cycle process | 45/1910 | 294/18723 | 3.73e-03 | 2.22e-02 | 45 |
GO:00023202 | Skin | AK | lymphoid progenitor cell differentiation | 7/1910 | 22/18723 | 4.88e-03 | 2.77e-02 | 7 |
GO:00064741 | Skin | AK | N-terminal protein amino acid acetylation | 6/1910 | 17/18723 | 5.13e-03 | 2.87e-02 | 6 |
GO:00031704 | Skin | AK | heart valve development | 14/1910 | 65/18723 | 5.22e-03 | 2.91e-02 | 14 |
GO:00720018 | Skin | AK | renal system development | 45/1910 | 302/18723 | 6.14e-03 | 3.31e-02 | 45 |
GO:00315706 | Skin | AK | DNA integrity checkpoint | 22/1910 | 123/18723 | 6.33e-03 | 3.38e-02 | 22 |
GO:0048483 | Skin | AK | autonomic nervous system development | 11/1910 | 47/18723 | 6.62e-03 | 3.50e-02 | 11 |
GO:00000755 | Skin | AK | cell cycle checkpoint | 28/1910 | 169/18723 | 6.83e-03 | 3.60e-02 | 28 |
GO:00031794 | Skin | AK | heart valve morphogenesis | 12/1910 | 55/18723 | 8.41e-03 | 4.16e-02 | 12 |
GO:20007565 | Skin | AK | regulation of peptidyl-lysine acetylation | 13/1910 | 63/18723 | 1.01e-02 | 4.81e-02 | 13 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 2 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SOX4 | SNV | Missense_Mutation | rs777539753 | c.1172N>T | p.Ser391Phe | p.S391F | Q06945 | protein_coding | deleterious(0) | possibly_damaging(0.854) | TCGA-A7-A6VW-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | CR |
SOX4 | SNV | Missense_Mutation | novel | c.1367A>T | p.Glu456Val | p.E456V | Q06945 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-AC-A8OP-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SOX4 | SNV | Missense_Mutation | novel | c.1210N>T | p.Asp404Tyr | p.D404Y | Q06945 | protein_coding | deleterious(0.01) | probably_damaging(0.936) | TCGA-MY-A5BD-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
SOX4 | SNV | Missense_Mutation | novel | c.1390G>C | p.Glu464Gln | p.E464Q | Q06945 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-VS-A9UC-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD |
SOX4 | SNV | Missense_Mutation | c.331G>C | p.Glu111Gln | p.E111Q | Q06945 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-CM-6674-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
SOX4 | SNV | Missense_Mutation | c.299N>G | p.Leu100Arg | p.L100R | Q06945 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SOX4 | SNV | Missense_Mutation | c.237N>T | p.Glu79Asp | p.E79D | Q06945 | protein_coding | tolerated(0.06) | benign(0.444) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
SOX4 | SNV | Missense_Mutation | c.237N>T | p.Glu79Asp | p.E79D | Q06945 | protein_coding | tolerated(0.06) | benign(0.444) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SOX4 | SNV | Missense_Mutation | novel | c.1252T>G | p.Ser418Ala | p.S418A | Q06945 | protein_coding | tolerated(0.16) | benign(0.021) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SOX4 | SNV | Missense_Mutation | novel | c.1166N>G | p.Ser389Cys | p.S389C | Q06945 | protein_coding | deleterious(0) | benign(0.009) | TCGA-AX-A3G3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |